OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2026-03-31-accounts

Registered number= 01723353 Charity number: 326374 THE BRITISH BLOOD TRANSFUSION SOCIETY (A company limited by guarantee UNAUDITED REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026

THE BRITISH BLOOD TRANSFUSION SOCIETY (A ¢ompany limitsd by guarantee) CONTENTS Page Raf&ranc8 and administrative datsils of thg Society, its Council mombars and advisors Councll mem￿1$. r•port Independent examiner's rnport Statement of financial activities Balan¢• sh$$t 10- 11 Notes to the financial statements 12-21

THE BRITISH BLOOD TRANSFUSION SOCIETY (A ¢ompany limitsd by guarantee) REFERENCE AND ADMINISTRATIVE DETAILS OF THE SOCIEfY. ITS COUNCIL MEMBERS AND ADVISERS FOR THE YEAR ENDED 31 MARCH 2026 Coun¢ll mombgrs Dr D Roberts Mrs C E George Iresigneil 7 October 20251 Dr I Sullivan {resigned 7 October 20251 Mr R C Hagga5, Treasurer Miss J Staves, President Mrs R Braund Dr N Osaro (resigned 7 October 2025) hAr D Gaskin DTKIMead Dr J Nash (appointed 7 October 20251 Miss S Wriqht lappointed 25 March 20261 Mr W Musabaike lappointed 21 Aprl 20261 Mr M Hazell lappoinled 7 May 20261 Company r•gl•t•r•d number 01723353 Charlty rnglstsr•d numbor 326374 Rogl•tsr•d offic• CIO Amslrong Walson 1st Floor One Slravbery Lane Newcasle Upon Tyne NE148X BBTS Ex¢¢utiv• Manager David Noble Accountants Amistrong Watson LLP Chartered Accountants First Hoor One Slrawbery Lane Newcasle Upon Tyne NE1 48X Solicitors Hay & Kilner LLP The Lumen Sl Jame5, Boulevard New¢asOe Helix Newcasue upon Tyne NE4 5BZ Page 1

THE BRITISH BLOOD TRANSFUSION SOCIETY (A ¢ompany limitsd by guarantee) COUNCIL MEMBERS. REPORT FOR THE YEAR ENDED 31 MARCH 2026 The Counul members present their annual report together v*lh the finanual stslements of The British Blood Transfusion Society for the year 1 April 2025 to 31 Mar¢h 2026. The ￿port serves the purposes of both a Council members, report and a directors, report under company law. The Council member5 confirm that the report and financial statements of the charitable company comply with the current stslutory requirements, the requirements of the charitstrAe ¢ompany'5 goveming docufflenl and the provisions of the Statement of Recommended Pra¢b'ce ISORPI applicable lo charities preparing their accounts in accordance with the Financial Reporting Slandard applicable in the UK and Republic of Ireland IFRS1021 (effective 1 January 20191. Structure. gov•rnan¢• and manag•m•nt . Govornlng documont The British Blood Transfusion Society was established in May 1983 as a company limited by guarantee govemed by its Memorandum and Artides of Association (revised September 20111. It is registered as a charity with the Charity Commission. Every member undertakes to contribute such an amount not exceeding £1, as may be required in the event of the Society being wound up vA)le he is a member or within one year after they cease to be a member. Appolntment of Councll fflomb•r8 The Council members consist of officers. elected members and Pasl President or President Elect. Officers consist of the President of the Society vtho holds office for years and the Secretary and Treasurer who hold office for three years. The President can remain as a Council member for a further year after retirement from the office of President. The Secretary and Treasurer are eligible for reappointment by Council, bul neither can serve more than six consecutive years in office. The elected Council members Shall be those members of the Councrf vtho a￿ not officers and shall each hold office for a period of three years,. so far as possitle they shall be made up of a mix of professional categories and be representative of the current membership.. Ihe period of office may be extended from lime to lime by the President for a year with a maximum of three extensions providing a maximum term of Six years. The Council members of the charitable company lexduding cwpted members) are rts directors for the purposes of Company law and Iruslees lor the purposes of charity law. The elected Council members hold office for a period of three years. Calls for nominations for officers and elected members of Council are made in the BBTS Bloodlines New51etter and also on the SorAety's website. Nominees musl be UK members and musl have been a member of the Society for a minimum of two years. Nominations musl be proposed and seconded by two Society members. Details of the nominees are then publisheo ¢)n the ballot papers. ¢. Induction and training of Council members All new Counal members are given an induction pack containing informats'on, links and paperwork about the roles and responsibilities of trustee5 published by the Charity Commission. They a150 receive pa51 Council meeting papers and dales of forthcoming Council meeting5. At the first meeting of the new Council. new members are introduced to individual Council members and specific areas of responsibilty for new members are discussed and agreed. The Society's office then provides all the necessary background inforniation and paper%￿)rk for new Council members, individual areas of responsibility. Page 2

THE BRITISH BLOOD TRANSFUSION SOCIETY (A ¢ompany limitsd by guarantee) COUNCIL MEMBERS. REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2026 Structur•. gov•rnance and manag•m•nt lcontlnuodl d. Organisation The Society is managed by the Counul members. are responsiNe for the strategic direction and overview of the work of the Society. The Counal members must number at least eight and not more than foLJrteen. all of whom must be members of the Society. Three Councl members linduding at least one officer) are needed for a quorum. There are Committees and sulF¢ommrttees of Council members that may Cl￿p1 members who are not members of the Council or Society. Cfropled members may not exceed thretyuarters of the lotsl number of such committees. These Committees indude the Executive Woting Committee, the Scientific Meetings Administration Committee, the Communications Committee and the Professional Affairs & Education Committee. The day lo day operations of the chanty are managed by the BBTS Execvlive Manager and a small team of stsff from an office based in Manchester. •. BBTS Enterprf808 Llmlt•d The ¢harity's ¥thollowned subsidiary was inwrporated in May 2003 and carries out trading aclivilie$ for the charity. The subsidiary gift aids profits to the charity, Subject to the retention of reserves for 11$ own working apital requirements. f. Rl$k management The members of the Council are responsible for overseeing the risks faced by the Society. Within thls process. detailed consideration of risks is delegated lo the Executive Manager. Risks are identified. assessed and conlrds established throughout the year. Risks a￿ held in a risk regisler. Council conducts ongoing reviews of the major risks lo which the Society is exposed. Page 3

THE BRITISH BLOOD TRANSFUSION SOCIETY (A ¢ompany limitsd by guarantee) COUNCIL MEMBERS. REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2026 oblo¢￿v•S. actlvll•s and p•rfomian¢• a. Obl•ctlve$ and a¢tlvbtbe$ The main aim of the Society is to athance for the pul￿1¢ benefft. the study of blood transfusion induding immunohaemalology and lo promote research and development into all aspects of blood transfusion pracli¢e. The objectives of the Society continue to be to= Provide education and training, induding professitinal development Provide a forum for discussion and communication and facilitate the exchange of ideas be￿en all groups throu9h scientific meetings. special interest groups ISIGS) and the website Foster links wth relevant national societies and organisations and ensure Society representation as appropriate Encourage research and development and disseminate information on new developments Contribute lo the production of professional guidelines and promote best practice in all aspects of Iranslusion medicine Ensure recognits'on as the Profess￿nal body for Iransfvsion medicine by the govemment. health services and the public Contribute lo the advancement of knovAedge and services in developing countries The Council gets itself annual objectives. in fvrtherance of the above main objectives of the Society. Each objective has a performance measure and responsibility is allocated lo a Council member or Council sub- committee. Performance against the annual objectives is ￿¥•evIe￿ al Counul meetings throughout the year and a progress report put4i$hed in the Annual Review for members to view. The Council confirm that they have been given the gerteral guidance produced by the Charity Commi55ion on public benefit Including the guidance 'public benefit running a charity IPB21'. The Council are confident that public benefit is acl)ieved through the study of blood transfusion and development. Ik Achlovoments and perforniance The Society's chartsble acts'vities focus on the sludy of transfusion and are undertaken to further ils Charitable purpose$ for the public benefil as described in the followng paragraphs.. The Society ddivered its annual conference event in October 2025. The conference was held al Harrogale HIC. The Soaety mel rts AGM obligations lo members on time. The Society continued to protect its finances during the year and worked hard for members lo ensure it an continue and expand on rts works and acts'vth'es in the years ahead. The education programme5 conkn.nue lo provide valuable education and training opportunities and Sel out tr8n5fusion best practice. 145 peoF4e look an examinatson with an overall 84% pa55 rale and 82 text books were separately pur¢hase<l. Our VLE sollWa￿ contsnues lo evdve and be upgraded. The Mo¢xlle exam platfomi sofvare, induding online marking, was upgraded and continues to perfomi well. The CPD scheme provides a specific framework for transfijsion professionals. This year the Society had 480 members vtho were both registered and acb.ve on the scheme. CPD News conb.nues lo provide members relevant opportunitses to learn and reflect. The Society continues to improve ils online CPD tool for members lo populate and submit retums ele¢troni¢ally. Through engagement with all members al every step the Society has continued to work closely with its Equality, Diversity and Indusion Committee esta￿lShing fvrther updated Temis of Reference. Page 4

THE BRITISH BLOOD TRANSFUSION SOCIETY (A ¢ompany limitsd by guarantee) COUNCIL MEMBERS. REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2026 Oblo¢￿V*s. actlvll•s and p•rfomian¢• {¢ontinu•dl Icontinuadl Successfully delivering six edition5 of the Society's Transffijsion Medicine joumal and four edrf(ions of ils membership magazine ￿(￿￿j1$￿eS. The Society has continued its represenlations as a professional body working towards the delivery of safe and effective transfusion practice. During the year, Council achieved many of rts major objectives induding the improvement of our online course delivery and online exams. maintaining a strong Transfusion Medicine impact factor and gaining a respectable financial return from this joumal. The Society continues to work hard to rewTite and add to its CTP course content, this project is now nearing conclusion. We are planning to relaunch the course this year. We provided three educational webinars. We created a PBM SIG for the first lime in the Society's history and created an Earfy Profes5iona15 Committee. We continued lo miligale financial risk lo the Society during this penod and we now have no external funding which means we are enlirdy financially IndependenL Membership of the Society ha$ Changed during the year a$ follows.. Number ol members on l April 2025 Number ol new members Number ol members who left Number of members on 31 March 2026 1.487 141 12271 1,401 Flnanclal rnvlèw a. Rosults The principal funding sources of the Society are from training income and membership subscriptions. Income from these sources is shown in note 5 to the financial Slalemenls. The nel movement in fijnds for the year was a deficit of £74.38612025.' £40.1951, as shown in the statement of financial activities. There was a gfft aid donation of £nil 12025.. £nill from the subsidiary thi5 year, so the operational deficit was £74,386 {2025. £40.1951. The group deficit for the year was £86,46012025". £50,381). Ik Rosorves policy Council has established a policy whereby the unrestricted funds not committed. designated or invested in tangible fixed assets (the free reserves) held by the group should equate to at least £400.000. The reserves are needed to meet the ongoing working capital requirements of the group, to bridge any funding gaps during the development of new activ￿eS and lo enable the group lo continue its current activities in the event of a 5ignrficant drop in income. The free reserves of the charty as at 31 March 2026 were £330,082 {2025.' £404,468) and those of the trading subsidiary add a further £66,721 12025 £78,795), a total of £396.80312025'. £483,263). Page 5

THE BRITISH BLOOD TRANSFUSION SOCIETY (A ¢ompany limitsd by guarantee) COUNCIL MEMBERS. REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2026 ¢. Inv•stmont po￿1$ and policy Under the Memorandum and Articles of Association, the Society has the power lo make investments as the Council members see fil. Having regard lo the Society's liquidity requirements and reserves policy. Council have, in recent years, operated a pdicy of keeping available funds in interest-bearing deposit accounts. d. Golng concorn After making appropriate enquiries, the Council members have a reasonable expectation that the Society has adequate resources lo continue in operational existence for the foreseeable future. For this rea50n, they continue lo adopt the going concem basis in prepanng the financial slatemenls. Further detsils regarding the adoption of the going concern basis can be found in the accounting pdiues. Plans for future periods The Council has set rtself a number of annual objeclives for 2026127. in ftjrtherance of the main objectives of the Society. These objectives indude the followng". building on the strategies for membership expansion.. conclude the Written update of ils Transfusion Science Practice COUTsebook', relaunch of ils Clinical Transfusion Practice course., lo continue the successftjl delivery of online webinars", conts'nually enhance our online exams to improve delivery and marking.. bring our SiGs and their goals doser lo the day to day work ol Council.. conlinue to r&enforce our rdationships wih oiher professional bodies,. launch a new membership grade for lower band transfusion woikers,. launch an Earfy Career Professionals membership grade.. launch a BBTS mentorship scheme". continue lo ensure ils finances a￿ adequate fdloV￿n9 wthdrawal of fvnding." review alternative conference venues to protecl our finan¢e$ and reserve$ Page 6

THE BRITISH BLOOD TRANSFUSION SOCIETY (A ¢ompany limitsd by guarantee) COUNCIL MEMBERS. REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2026 Statsm•nt of Councll m•mb•rn' rnsponsibllltlos The Council members (who are also the directors of the Society for the purposes of company lawl are responsible for preparing the Council members. report including the Strategic report and the financial stslements in accordance wlh applicable law and Untied Kingdom Accounb"ng Stsndards (United Kingdom Generally Accepted Accounbng Pra¢ti¢el. Company law requires the Council members to prepare financial slalements for each financial year. Under company law. the Council members musl not approve the financial stslements unless they a￿ satisfied that they give a Inje and fair view of the slate of affairs of the Society and ol ils in¢oming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Council members are required to.. seled sulta￿e accounting poliues and then ap￿Y them ￿nsIsten0Y., observe the method5 and princiF4es of the Charities SORP IFRS 1021., make judgments and accountsng esbmales that are reasonable and prudent.. slate whether applicable UK Accounting Standards IFRS 1021 have been followed, subject to any material departures disdosed and explained in the financial slalemenls., prepare the financial statements on the going concern basis unless il is inappropriate lo presume that the Society will continue in business. The Council members are responsitAe for keeping adequate accounting records that are sufficient lo show and explain the Society's transactions and di$dose wth reasonable a￿￿Ta¢Y at any lime the financial position of the Society and enable them to ensure thal the financial slatements comply wih the Companies Act 2006. They are also responsible for safeguarding the assets of the Society and hence for taking reasonable steps for the prevention and detection ol fraud and other irregularities. Approved by order of the members of the board of C¢)uncil members and signed on their behalf by.. Mlss J Staves (Chair of Tru5teesl Dale.. 1110912026 Page 7

THE BRITISH BLOOD TRANSFUSION SOCIETY (A ¢ompany limitsd by guarantee) INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDED 31 MARCH 2026 Independent examiner's report to the Coun¢il mèmbets of The British Blood Trnnsfusion Soci&ty I'the So¢igty'1 I report lo the chanty Council member5 on my examination of the accounts of the Society for the year ended 31 March 2026. Responsibilities and basis of report As the Council members of the So¢iety land ils directors foc the purposes of company lawl you are responsible for the preparation of the a￿￿￿ts in ac￿rdanCe Ihe requirement$ of the Companie$ Act 20061'lhe 2006 Act'l. Having satisfied mysdf that the accounts of the Society are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the Society's accounts carried out under section 145 of the Charities Act 2011 {Ihe 2011 Act'l. In carrying out my examination I have followed the Directions given by the Charity Commission under section 1451Sllbl of the 2011 Act. Independent examln•r'$ ststemont Since the Society's gross income exceeded £250,000 your examiner musl be a member of 8 body listed in section 14S of the 2011 Act. I confirm that l am qualified to undertake the examinats'on because l am a member of ACA, which is one of the listed bodies. I have com￿eted my examination. I confim that no matters have come lo my attention in connection the examinion giving me cause lo believe.. accounting records were not kept in respect of the Swety as required by section 386 of the 2006 Act,. or the accounts do not accord wth those records." or the accounts fjo not ¢omF4y wrth the accounting ￿qUIrementS ol section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fairf view which 1$ not a matter ¢onsidered as part of an independent examinats'on., or the accounts have not been prepared In accordance wth the methods and principle5 of the Slalemenl of Recommended Practice for accounting and reporting by charities lappli¢aUe lo charities preparing their accounts in accordance wrth the Financial Repo￿"n9 Stsndard applicable in the UK and Republic of Ireland IFRS 10211. I have no concerns and have come across no other matters in o)nnecb'on wlh the examination lo which attention should be drawn in this report in order lo enat a proper understanding of the accounts lo be reached. This report is made solely lo the So¢ieVs Cound members. as a body. in accordance ￿th Part 4 of the Charities (Accounts and Reports) Regulations 2008. My work has been undertaken so that I might state to the Society's Council members those matters l am required to state to them in an Independent examinerfs report and for no other purpose. To the fullest extent pemitted by law, I do not accept or assume responsibility to anyone other than the Society and the Socielys Council members as a body, for my work or for this report. Dated.. 1110912026 E Chapthwé*pman (Ocl Amistrong Watson LLP One Strawberry Lane Newcastle upon Tyne NE1 4BX 0 2026 10 49.'33 GMT) Independent Examiner Page 8

THE BRITISH BLOOD TRANSFUSION SOCIETY (A ¢ompany limitsd by guarantee) STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNTI FOR THE YEAR ENDED 31 MARCH 2026 Unr•strl¢tsd funds 2026 Totsl funds 2026 Total funds 2025 Income from: Donations 1,528 11,084 268.437 1,S28 11,084 268,437 14,215 74,099 267,852 Investments Charitable acliwtses Total incom8 281.049 281,049 290, 166 Expondlture on: CharIta￿e acliwbes 355.435 355,435 330,361 Total oxpondltur¢ 3SS.435 355,435 330,361 Not l•xpendlturo1 Incom• and movom•nt In lund• 174,386) 174,3861 (40. 195) Ro¢on¢lllatlon of funds: Total funds brought forward Net movement in funds 404,468 174.386) 404,468 174,3861 444,663 (40, 195) Total funds carrl•d forKdrd 330,082 330,082 404,468 The Statement of financial activities inclLths all gains and losses recognised in the year. The notes on pages 12 to 21 form part ol these financial statements. Page 9

THE BRITISH BLOOD TRANSFUSION SOCIETY IA Company limitsd by guarantetrl REGISTERED NUMBER: 01723353 BALAMCE SHEET AS AT 31 MARCH 2026 2026 2025 Mole Fixed assets Intangible assets Tangible assets Inve51ment5 10 38,499 3,082 44,956 2,857 12 41,582 47,814 Current assets Debtors Cash al bank and in hand 13 177,358 282,957 783.893 312,469 460,315 496,362 Current Ilabllltl•s Creditors.. amounts falling due wlhin one year 14 1166,7491 (133,376) Not currnnt a##èt* 293,566 362.986 Totsl ass•ts1g$$ ¢urrnnt1Sabilltles 33S,148 410,800 Capital grant 15,0661 (6,3321 Net assets 330,082 404.468 Total net assots 330,082 404,468 Page 10

THE BRITISH BLOOD TRANSFUSION SOCIETY IA Company limitsd by guarantetrl REGISTERED NUMBER: 01723353 BALANCE SHEET (CONTINUED) AS AT 31 MARCH 2026 2026 2025 Mole Charity funds Reslricled lunds Unre$tri¢ted fund$ 15 15 330,082 404,468 Total funds 330,082 404.468 The Society was entitled lo exempb.on from audit under section 477 of the Companies Act 2006. The members have not required the company lo obtain an audr( for the year in question in accordance wth section 478 of Companies Ad 2006. The Council members acknovAedge their responsibilrties for complying wth the requiremen15 of the Act with respect lo accounting re￿rdS and preparatson of finanual slatemenls. The financial slalemenls have been prepared in accordance the provisions applicable lo enlilies subject lo the Small ¢gmpanie$ regime. The financial statements were approved and aulhorised for issue by the Council members and gigned on their behalf by.. Mig9 J Stsves (Chair of Trusleesl Dale., 1110912026 The notes on pages 12 to 21 form part of these financial stalements. Page 11

THE BRITISH BLOOD TRANSFUSION SOCIETY (A ¢ompany limitsd by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026 General infomiation The Society Is a company limited by guarantee and has no share capital. The liability of each member in the event of wnding up is limited to £1. Accounting poll¢l•s 2.1 8asis of preparation of financial statements The financial statements have been prepared in ae¢ordanee wlh the Charities SORP IFRS 1021 Accounting and Reporting by Chanties." Slalement of Recommended Practice applicable to charities preparing their accounts in accordance ￿th the Financial Repo￿.ng Stsndard applicable in the UK and Republic of Ireland IFRS 1021 leffectsve 1 January 20191, the Financial Reporting Standard applicable in the UK and Republic of Ireland IFRS 1021 and the Companies Act 2006. The financial statements are ￿pared in Sterling %thi¢h 1$ the fun¢b"onal and presenlab'on currency of the charity. The British Blood Transfvsion Society meets the definition of a public benefit entity under FRS 102, Assets and liabilities are initially reco9niged at historical eosl or Iran$4ction valuè unlegy otherwisè staled in the relevant accountsng policy. 2.2 Income All income is induded in the statement of financial ath'vities when the charity is entided to the income and the amount can be quantified with reasonable accuracy. The following specrfic policies are applied to particular categories of income.. Ck>nations are received by vray of grants and donations and are included in fvll in the Stslement of financial activities on a re¢eivat4e basis. The balan¢e of income received for spe¢ifi¢ purposes bul not expended during the period is shown in the relevant fvnds on the Balance sheet. Where income is received in advance of entitlement of receipt, its recognition is deferred and included in creditors as deferred income. Vvhere enlrtlement occurs before income is received, thè income is accrued. Income from charitable acts'vibes includes income from membership subscriptions and training and is recognised in the period in which the Society is entiljed to receipt. Deferred income represents amounts received for future periods and is released to the statement of finanaal activities for the period for which rt has been released. 2.3 Exptrnditur• Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third paty, rt is probat4e that a transfer of economic benefits will be required in se￿ement and the amount of the obligation can be measured reliably. Expenditure is dassified by acb"vty. The costs of each actiwty a￿ made up of the total of direct costs and shared co$ls. induding support costs invrAved in undertaking each activity. Direct costs attributat4e lo a single activty are allocated direcdy to that activty. Shared costs which contribute lo more than one activity and support costs ￿lch are not attributable lo a single activity are apportioned between those activrb.es on a basi5 con51slent wth the use of resour¢e5. Expenditure on ¢harit3Ne activities is incurred on directly undertakn'ng Ihe a¢tivrties which ftjrther the Society's objectives, as well as any associated support costs. Page 12

THE BRITISH BLOOD TRANSFUSION SOCIETY (A ¢ompany limitsd by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026 Accounting poli¢io5 Icontinu•d} 2.3 Expenditure (continued) All expenditure is indusive of irrecoverable VAT. 2.4 Internst r8c•ivable Interest on funds held on deposit is included when receivatle and the amount can be measured reliably by the Souety", this is normally upon nolificatson of the interest paid or payable by the institution wth whom the funds are deposrted. 2.5 Intsngible assets and amortisation Intangible assets are inrtially recognised at cosL After recognition, under the cost model, intangible assets are measured al cost less any acCuM￿ated amorts"salion and any accumulated impairment losses. Amortisation is provided on intangible assets at rates caculaled lo write off the cost of each asset on a straight-line basis over its expected useful life. The eslimaled useful lives are as follows.. Website costs S years 2.6 Tanglblo flx•d a880ts and d•pr8clatSon Tangit4e fixed assets are induded in the finanual Stslemenls al their historical cost. Depreciation is charged so as to allocate the cost of tangible fixed assets less their ￿SIdUal value over Iheir eslimaled uselul lives. Depreciation is provided on the following basis.. Fixtu￿$ and fittings Computer equipment 20% On straight line basis 25% On slraight line basis 2.7 Investments The investment in the subsidiary undertaking is induded in the financial 51atemenls al cost. The financial slalemenls for the Society indude only the indwidual parent charty and are not consolidated lo indude the trading subsidiary. The pa￿nI Charity is not required lo prepare consolidated financial statements under section 399 of the Companies Act 2006 and is excepted by section 139121 of the Chariiies Act 2011 from the requirement to prepare group accounts. 2.8 Debtors Trade and other debtors are re¢ognised * the setdement amount after any trade discount offered. Prepayments are valued at the amount prepaKI net of any trade discounts due. 2.9 C•sh at bank and in hand Cash at bank indudes a current account and an instsnt access COIF Charities Deposit Fund account Page 13

THE BRITISH BLOOD TRANSFUSION SOCIETY (A ¢ompany limitsd by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026 Accounting poli¢io5 Icontinu•d} 2.10 Liabilities Liabilities and provisions are recognised when there is an olAigalion at the Balance sheet dale as a result of a past event. rt is probable that a transfer of economic benefit will be required in setdement. and the amount of the settlement can be estimated reliably. Liabilities are recognised at the amount that the Society anlicipates il will pay lo settle the debt or the amount il has received as advanced payments for the goods or service5 11 mu51 provide. 2.11 Flnanclal Instruments The Society only has financial assets and financial liablities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequendy measured at their settlement V￿ue. 2.12 Fund Structure General funds are unrestricted funds vthich are availaL4e for use at the discretion of the Council members in furtherance of the gener￿ objectives of the Society and which have not been designated for other purposes. The general fund is credited wth subs¢riplion$ received from members and income from Iraining ￿Urse$ and associated income.11 is charged with the charitable expendrture anil governance cosls of the Society. Designated funds comprise unresiricted funds that have been sel aside by the Council members for particular purposes. The aim and use of any designated fund is set out in the notes to the financial slalemenls. Grants obtained for specffic PU￿Se$ a￿ recognised in the financial stslemenls as ￿$triCted funds. Investment income, gains and losses are allocated to the appropriate fund. 2.13 Judgemonts and key Sources of estimation uncèrtainty In apk￿￿ng the Societys accounting policies. the Council members are required lo make judgements. estimates and assumptions in delemining the carrying amounts of assets and liabilities. The Coun￿1 members. judgements, estimates and assumptions are based on the best and most reliable evidence available at the time when the decisions are made, and are based on historical experience and other factors that are considered lo be applicable. Due lo the inherent subjeclivty involved in making such judgements. estimates and assumptions. the actual results and outcomes may drffer. The estimates and undetlying assumptions are reviewed on an ongoing basis. Revisions lo accounting estimates are recognised in the period in which the estimate is revised, if the rewsion affects onty thal penod, or in the period of the revision and future periods. if the revision affects both current and future periods Page 14

THE BRITISH BLOOD TRANSFUSION SOCIETY (A ¢ompany limitsd by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026 Income from donations Unrnstrictsd Ro$trictsd funds funds 2026 2026 Total funds 2026 Donations Grants 262 1,266 262 1,266 1.528 1.528 Unrnslncled funds 2025 R8slncled funds 2025 Total funds 2025 Don8li¢ns Grants 215 215 14,000 14,000 215 14,000 14,275 Invo•tmont Income Unrestrlcted funds 2026 Total funds 2026 Total funds 2025 Bank interest 11,084 11,084 14,099 Charitable activities Unrostrlctsd funds 2026 Total funds 2026 Total funds 2025 Membership subscriptsons Training 115,388 153,049 11S,388 153,049 919,621 142,231 268.437 268,437 261,852 Page 15

THE BRITISH BLOOD TRANSFUSION SOCIETY (A ¢ompany limitsd by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026 Independent examiner's remuneration 2026 2025 Fees payable to the Societys indeperKlent examiner for the independent examination of the Socaety's annual accounts Fees payable lo the Soi?eWs independent examiner in respecl ot. All other services not induded above 1.640 1,320 9,143 8,418 Total rnsources eX￿nd•d Charftsb Govemanco Total Tol81 actlvltles costs 2026 2025 Direct costs Publicity and publicatsons Educational programme Modernisino Scientific Careers 2,862 119,622 24,749 2.862 2,722 119,622 110,974 24,749 24,121 Allocated support costs Staff costs Office costs Depreciation and amortisalion Accountancy lee$ Legal and other professional fees 110,061 40.070 7,484 5,007 539 19,423 129,484 117,546 17.173 57,243 63,868 3,208 10,692 867 5,006 10,013 9,002 231 770 1,267 Stsff ¢osts and nUm￿r$ 2026 2025 Waoes and salaries National insurance costs Pension costs 17S,579 12,890 762,765 8, 149 198 426 782 639 Average number of employees in the year (all management and adminislralivel Page 16

THE BRITISH BLOOD TRANSFUSION SOCIETY (A ¢ompany limitsd by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026 Council members. remuneration and expenses During the year, no Councl members received any remuneration or other benefits (2025- £NIL). During the year ended 31 March 2026, expenses totalling £457 were reimbursed or paid diredy to 4 Council members (2025- £2.386 to 6 Counul membersj. 10. Intsnglble a$s•ts Wobslts Cost Al 1 April 2025 Additions 44,9S6 3.168 Al 31 March 2026 48.124 Amortl8atlon Charge for the year 9.625 Al 31 March 2026 9.625 Not book value Al 31 March 2026 38.499 Al 37 Ma￿￿ 2025 44,956 Page 17

THE BRITISH BLOOD TRANSFUSION SOCIETY (A ¢ompany limitsd by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026 11. Tangible fixed assets Fixturns and fittings Computar oquipmont Totsl Cost or valuatlon At 1 April 2025 Additions 9,122 9,598 1.293 18,718 1,293 Al 31 March 2026 9.122 10,889 20,011 D•preclatlon Al 1 April 2025 Charge for the year 9,122 6,739 1,068 15,861 1,068 Al 31 March 2026 9.122 7,807 16,929 Not book value Al 31 March 2026 3,082 3,082 Al 31 Ma￿￿ 2025 2,857 2,857 12. Flx•d assot Inv•stm•nts Investments In subsldlary companios Cost or valuatlon At 1 April 2025 Al 31 March 2026 Ngl book value At 31 March 2026 Al 31 Ma￿h 2025 Page 18

THE BRITISH BLOOD TRANSFUSION SOCIETY (A ¢ompany limitsd by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026 13. Debtors 2026 2025 Due viithin one year Trade debtors Amounts due from subsidiary undertakings Prepayments and accrued income 14.252 132,588 30.518 10.702 f 44,613 28,578 177,358 783.893 1& Credllors: Amounts falling du• vAthin ong yoar 2026 2025 Trade crgtjitors Other taxation and social security Other creditors Accruals and defer￿d income 27,041 14.285 715 124,708 10,304 5,846 6, 787 110.445 166,749 133,376 2026 2025 Deferred income al l April 2025 Resources deferred during the year Amounts released from previous periods 100,075 91,906 1100.075} 104.263 100,075 (704,2631 91,906 100.075 Page 19

THE BRITISH BLOOD TRANSFUSION SOCIETY (A ¢ompany limitsd by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026 1& Statement of funds Statom•nt of lund$- Current year Balanc8 at 31 March 2026 Balance at 1 April 2025 Income Expenditure Unrestrictèd funds 404.468 279.783 {354.1691 330,082 Gener￿ funds 16. Analys1$ of n•t a$￿ts bOt￿n lund• Analysis of not a$$gts bgt¥wen funds- ¢urrnnt yo•r UnrnBtrlcted fund6 2026 Total lunds 2026 Tangible fixed assets Intangible fixed assets Fixed asset investments Current assets Creditors due wthin one year Capital grant 3,082 38,499 3,082 38.499 460,315 1168,7491 15,0661 460,315 1166,7491 15.0661 Total 330,082 330,082 Analysis of not assets bet￿￿n funds. prior year un￿$t17cl8d funds 2025 Total funds 2025 Tangible fixed assets Intangible fixed assets Fixed asset investments Current a5set5 Creditors due wrthin one year Capital grant 2,85T 44,956 2,857 44,956 496,362 (133.376) (6,332) 496,362 (133.316) (6,332) Total 404.468 404.468 Page 20

THE BRITISH BLOOD TRANSFUSION SOCIETY (A ¢ompany limitsd by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026 17. Principal subsidiaries The following We￿ subsidiary undertakings of the Society- Namos Company number Principal plac8 Class of Holding of business shares BBTS Enterprises Limited 4775642 England Ordinary 100% The finan¢ial results of the subsidiary for the year were.. Name Incom• Expenditure Deficit for the year BBTS Enterprises Limited 42S.846 437,920 112,0741 Not as80ts 76,721 Page 21